Review: chronic inflammation, weathering and proposed precision-medicine approaches to biological aging
This review abstract links adverse social environments and chronic stress to accelerated biological aging via chronic low-grade inflammation and the weathering framework, and discusses senolytics, anti-inflammatory agents and RNA-based approaches as largely experimental options. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract says adverse social environments, chronic stress and socioeconomic disadvantage can accelerate biological aging by altering age-related biomarkers and stress-response pathways. [1]
The abstract names chronic low-grade inflammation as a central mechanism contributing to age-related conditions including cancer and neurodegenerative diseases. [1]
The abstract states that RNA-based therapies remain largely experimental and their clinical translation for stress-related aging and health disparities has yet to be established. [1]
The source at a glance
- Study type / format
- Review (abstract only)
- Population / context
- People affected by social disadvantage and accelerated biological aging, with particular mention of Caribbean Hispanics.
- Summary based on
- Study abstract
- Original publication
- July 21, 2026
Weathering and inflammation in biological aging
The abstract describes biological aging as a gradual, multisystem process with functional decline, reduced physiological resilience and greater susceptibility to chronic disease. It says growing evidence suggests persistent adverse social environments, chronic psychological stress and socioeconomic disadvantage can accelerate biological aging by altering age-related biomarkers and stress-response pathways. The weathering hypothesis is presented as a framework for how cumulative psychosocial adversity becomes biologically embedded, causing wear and tear that hastens age-related deterioration. Chronic low-grade inflammation is named as a central mechanism contributing to age-related conditions such as cancer and neurodegenerative diseases.
Supporting source [1]
Caribbean Hispanics and proposed therapeutic strategies
The abstract states that cancer and neurodegenerative diseases are highly prevalent among Caribbean Hispanics, a population described as disproportionately affected by social disadvantages and rapid population aging. It reports that advances in inflammation biology and cellular senescence have generated interest in strategies that modulate fundamental aging mechanisms. Senolytics, anti-inflammatory agents and non-coding RNA-based interventions are described as emerging approaches with promising opportunities for precision medicine. The abstract explicitly notes that RNA-based therapies remain largely experimental and that their clinical translation for stress-related aging and health disparities has yet to be established.
Supporting source [1]
Review scope: proposed precision medicine, not proven benefit
The authors frame the work as a review examining how weathering and inflammation interact in shaping biological aging and discussing the potential of innovative precision medicine approaches to mitigate age-related decline and reduce health disparities in vulnerable populations. The abstract reports no study design details, sample, follow-up or measured outcomes for the therapeutic approaches; these are described as emerging and, for RNA-based therapies, largely experimental. The abstract therefore supports associations and proposals, not demonstrated causal effects or clinical benefit in humans.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. No study design, sample, follow-up or measured outcomes are reported for the therapeutic approaches, which are described as emerging and, for RNA-based therapies, largely experimental. Associations and proposals are not evidence of causal effects or clinical benefit.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Marin-Maldonado FM, Santiago-Rosario MJ, Fonseca-Ferrer W, Vlaar CP, Martinez-Ferrer M, Colon-Saez J, Duconge-Soler J. · europepmc.org · July 21, 2026